|
GenScript corporation
synthetic, codon optimized p. vivax dxs gene Synthetic, Codon Optimized P. Vivax Dxs Gene, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/rifin++7++pf3d7+1040300+/pmc03668541-42-2-22 Average 90 stars, based on 1 article reviews
synthetic, codon optimized p. vivax dxs gene - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
NCIMB Ltd
codon-optimized aldh from clostridium beijerinckii ncimb 8052 Codon Optimized Aldh From Clostridium Beijerinckii Ncimb 8052, supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/codon+optimized+aldh+from+clostridium+beijerinckii+ncimb+8052/pmc10619544__SC___014___D3SC02773B___s001-319-107-113 Average 90 stars, based on 1 article reviews
codon-optimized aldh from clostridium beijerinckii ncimb 8052 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Promega
codon-optimized control promega Codon Optimized Control Promega, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/codon+optimized+control+promega/pmc10935487-180-6-8 Average 90 stars, based on 1 article reviews
codon-optimized control promega - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Azenta
bapat Bapat, supplied by Azenta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/bapat/pm39007091-152-11-16 Average 90 stars, based on 1 article reviews
bapat - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
TriLink
mrnas for egfp, mcherry and epcam × cd3 bite ![]() Mrnas For Egfp, Mcherry And Epcam × Cd3 Bite, supplied by TriLink, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/mrnas+for+egfp++mcherry+and+epcam+%C3%97+cd3+bite/pmc08840964-48-0-13 Average 90 stars, based on 1 article reviews
mrnas for egfp, mcherry and epcam × cd3 bite - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Eurofins
codon optimized gblock ![]() Codon Optimized Gblock, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/codon+optimized+gblock/us11879134-232-8-11 Average 90 stars, based on 1 article reviews
codon optimized gblock - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Eurofins
akaluc ![]() Akaluc, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/akaluc/pmc11025001-292-0-6 Average 90 stars, based on 1 article reviews
akaluc - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Eurofins
codon-optimized cdc42 ![]() Codon Optimized Cdc42, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/sirna+targeting+cdc42++sicdc42+1++cuaugcagucacaguuaugtt/pmc06910828-187-8-12 Average 90 stars, based on 1 article reviews
codon-optimized cdc42 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Amaxa
codon-optimized maxgfp ![]() Codon Optimized Maxgfp, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/codon+optimized+maxgfp/us09217157-1352-15-17 Average 90 stars, based on 1 article reviews
codon-optimized maxgfp - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
codon-optimized microdystrophin ![]() Codon Optimized Microdystrophin, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/codon+optimized+microdystrophin/pm38713520-184-0-5 Average 90 stars, based on 1 article reviews
codon-optimized microdystrophin - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Eurofins
codon-optimized version of the sgd1 coding sequence ![]() Codon Optimized Version Of The Sgd1 Coding Sequence, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/sgd1+coding+sequence/pmc07237134-221-10-21 Average 90 stars, based on 1 article reviews
codon-optimized version of the sgd1 coding sequence - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sangamo Inc
codon-optimized fix ![]() Codon Optimized Fix, supplied by Sangamo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p%2E+vivax+dxr+codon-optimized+gene/codon+optimized+fix/pmc06913446-8-4-0 Average 90 stars, based on 1 article reviews
codon-optimized fix - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of controlled release : official journal of the Controlled Release Society
Article Title: BiTE secretion from in situ -programmed myeloid cells results in tumor-retained pharmacology
doi: 10.1016/j.jconrel.2021.12.029
Figure Lengend Snippet: BiTE-encoding nanoparticles can imprint a pro-inflammatory M1-like phenotype. (a) Experimental timeline of the gene expression study. (b) Heat map of signature gene expression in nanoparticle-transfected (mCherry+) myeloid cells sorted from ovarian tumor-bearing mice following EpCAM × CD3 BiTE mRNA nanoparticle therapy or PBS control treatment. Abundances of mRNAs were normalized by z-scores created with the equation z = ( x- x ¯ ) / SD ( x ) . (c-e) Violin plots showing counts for the indicated genes. N = 6 biologically independent samples.
Article Snippet:
Techniques: Gene Expression, Transfection, Control
Journal: Journal of controlled release : official journal of the Controlled Release Society
Article Title: BiTE secretion from in situ -programmed myeloid cells results in tumor-retained pharmacology
doi: 10.1016/j.jconrel.2021.12.029
Figure Lengend Snippet: Macrophage transfection with BiTE-encoding mRNA nanocarriers results in functional BiTE protein secretion. (a) Design of macrophage-targeted polymeric nanoparticles formulated with mRNAs encoding the CD3 × EpCAM bispecific antibody. The particles consist of a PbAE-mRNA polyplex core coated with a layer of PGA-Di-mannose, which targets the particles to mannose receptors (CD206). Also depicted is the synthetic mRNA encapsulated in the nanoparticles, which is engineered to encode the bispecific antibody. (b) Flow cytometric analysis of gene-transfer efficiencies into RAW 264.7 macrophages. (c) Immunoblot detection with an IRDye 680RD Streptavidin-conjugated antibody to C-tagged CD3 × EpCAM bispecific antibody in supernatants from nanoparticle-transfected RAW 264.7 macrophages. Positive control, 25 ng of the corresponding purified recombinant BiTE protein. (d) ELISA measurements of EpCAM × CD3 BiTE protein production by nanoparticle-transfected (mCherry + ) RAW264.7 cells. Assays were performed in triplicate. (e-j) Assessing T-cell activation, cytokine secretion and cytotoxicity against tumor cells. (e) Schematic representation of in vitro cell-killing assays conducted by adding escalating doses of rBiTE into co-cultures of tumor cells and naive T cells. ID8 EpCAM cells are lentivirally engineered versions of ID8 ovarian tumor cells that stably express EpCAM. Tumor lysis and T-cell activation were evaluated by bioluminescent imaging and flow cytometry, respectively, after 72 h of incubation. (f) Bioluminescence imaging of ID8 cells or ID8 EpCAM cells cultured in 96-well plates under different conditions. (g) Levels of bioluminescent signals in (f) were summarized as normalized average radiances in a dose-response curve. (h) Representative flow cytometric histograms demonstrating T-cell proliferation after 72 h of co-culturing with tumor cells in the presence of different amounts of rBiTE. (i) Flow cytometric quantitation of activated T cells. (j) Cytokine secretion was determined by Luminex assay. Assays were performed in triplicate. Means ± SD are depicted. NP, nanoparticle; rBiTE, recombinant BiTE protein.
Article Snippet:
Techniques: Transfection, Functional Assay, Western Blot, Positive Control, Purification, Recombinant, Enzyme-linked Immunosorbent Assay, Activation Assay, In Vitro, Stable Transfection, Lysis, Imaging, Flow Cytometry, Incubation, Cell Culture, Quantitation Assay, Luminex
Journal: iScience
Article Title: Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
doi: 10.1016/j.isci.2024.109647
Figure Lengend Snippet: The virological features of SARS-CoV-2 Akaluc in vitro (A) The gene structures of wild-type SARS-CoV-2 (B.1.1) and SARS-CoV-2 carrying either the wild type or codon-optimized Akaluc luciferase gene in place of ORFs 6–8. (B) Viral production was judged by observation of cytopathic effects upon transfection with the transfection of each CPER product for 3 respective genomes. Representative images are shown from 6 days post transfection. Scale bars: 100 μm. (C) Northern blot analysis of subgenomic RNAs (sgRNAs). RNA was extracted from VeroE6/TMPRSS2 cells infected with B.1.1 or B.1.1-Akaluc and subjected to northern blot analysis. Black arrows indicate the bands for each sgRNA with size in parentheses. (D) Growth kinetics of B.1.1 and B.1.1-Akaluc in vitro . VeroE6/TMPRSS2 cells were infected with either B.1.1 or B.1.1-Akaluc (MOI = 0.001). Infectious titers in the culture supernatants (left panel), the copy number of intracellular viral RNA (middle panel), and the luciferase activity (right panel) were determined at the indicated timepoints. The luminescence intensity was normalized with the signals acquired from uninfected VeroE6/TMPRSS2 cells. Asterisks indicate significant differences (∗, p < 0.05) with the results of the wild-type virus. The presented data are expressed as the average ±SEM. Assays were performed independently in duplicate.
Article Snippet:
Techniques: In Vitro, Luciferase, Transfection, Northern Blot, Infection, Activity Assay, Virus
Journal: iScience
Article Title: Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
doi: 10.1016/j.isci.2024.109647
Figure Lengend Snippet: Mutations of the B.1.1-Akaluc after the serial passages
Article Snippet:
Techniques:
Journal: iScience
Article Title: Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
doi: 10.1016/j.isci.2024.109647
Figure Lengend Snippet: The virological features of B.1.1-Akaluc in vivo (A) Syrian hamsters (n = 6 per group) were intranasally inoculated with saline, B.1.1, or B.1.1-Akaluc. Body weight was measured daily through 7 days post-infection (dpi). (B) In vivo bioluminescence imaging of hamsters inoculated with B.1.1-Akaluc was performed daily through 7 dpi and again at 10 dpi. A representative image from an infected hamster is shown. The image was acquired after intraperitoneal injection of AkaLumine-HCl (75 nmol/g). (C) Syrian hamsters (n = 6) were intranasally inoculated with B.1.1-Akaluc. Viral RNA copies in the oral swab (left panel) and the luminescence intensity of the nasal cavity of hamsters (middle panel) inoculated with B.1.1-Akaluc were measured every 24 h through 7 dpi and then again at 10 dpi. NA: Not applicable. ND: Not detected. The area of measurement of the luminescence intensity are shown in the representative image (right panel). (D) IHC of the viral N protein (stained brown) in the nasal cavity, olfactory bulb, trachea, and lungs of hamsters at 3 dpi with B.1.1-Akaluc. Representative figures are shown. Scale bars: 200 μm. HE, hematoxylin and eosin. (A and C) The presented data are expressed as the average ±SEM.
Article Snippet:
Techniques: In Vivo, Saline, Infection, Imaging, Injection, Staining
Journal: iScience
Article Title: Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
doi: 10.1016/j.isci.2024.109647
Figure Lengend Snippet: The virological features of B.1.1-NanoLuc in vivo (A and B) Syrian hamsters (n = 6) were inoculated with B.1.1 carrying the NanoLuc luciferase gene (B.1.1-NanoLuc). Bioluminescence imaging of hamsters was performed daily through 3 dpi and a representative image from an infected hamster is shown (A). Oral swabs were collected (B, left panel) and the luminescence intensity of the nasal cavity (B, right panel) measured daily through 3 dpi. The images were acquired after intraperitoneal injection of FFz (440 nmol/g). (C) The lung hilum was harvested at 3 dpi and for quantification of viral RNA. Two hamsters infected with B.1.1-Akaluc served as controls. (B and C) The presented data are expressed as the average ±SEM.
Article Snippet:
Techniques: In Vivo, Luciferase, Imaging, Infection, Injection
Figure S3 showing the sections of all four lung lobes. (E) H&E staining of the areas in Journal: iScience
Article Title: Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
doi: 10.1016/j.isci.2024.109647
Figure Lengend Snippet: The virological features of SARS-CoV-2-Akaluc variants in vivo Syrian hamsters (n = 6 per group) were intranasally inoculated with B.1.351.1-Akaluc and BA.1-Akaluc. (A) Akaluc bioluminescence imaging of hamsters inoculated with the two viruses was performed daily through 3 dpi. Representative images are shown. The images were acquired after intraperitoneal injection of AkaLumine-HCl (75 nmol/g). (B) Viral RNA was quantified in oral swabs and the luminescence intensity of the nasal cavity of hamsters was measured daily through 3 dpi. (C) At 3 dpi, the lung hilum was harvested from hamsters and the viral RNA levels quantified. (D) IHC of the viral N protein (stained in brown) was assessed in the nasal cavity, trachea, and lungs at 3 dpi. Representative figures are shown. Scale bars: 100 μm. Percentage of N-positive cells in whole lung lobes (n = 3 per infection group) are shown (right panel). See
Article Snippet:
Techniques: In Vivo, Imaging, Injection, Staining, Infection
Figure S2 F. Bioluminescence imaging was performed at 3 dpi. (E) Representative images from infected mice (immunized and non-immunized) at 3 dpi. are shown. The images were acquired after intraperitoneal injection of AkaLumine-HCl (75 nmol/g). (F) The lung hilum was collected at 3 dpi and subjected to viral RNA quantification. " width="100%" height="100%">
Journal: iScience
Article Title: Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
doi: 10.1016/j.isci.2024.109647
Figure Lengend Snippet: Evaluation of the immunoprophylactic ability of SARS-CoV-2 monoclonal antibodies and mRNA vaccine (A) Schematic diagram of the experimental timeline for the evaluation of AZD7442 (Tixagevimab-Cilgavimab). One day before challenge, hamsters were immunized by AZD7442 (1 mg per dose) or isotype as control. Hamsters were inoculated with B.1.1-Akaluc (n = 6), or XBB.1.5-Akaluc (n = 6). One hamster in the XBB.1.5-Akaluc cohort unexpectedly died during the experiment. (B) Akaluc bioluminescence imaging was performed daily through 3 dpi. The images were acquired after intraperitoneal injection of AkaLumine-HCl (75 nmol/g). (C) The lung hilum was harvested at 3 dpi and subjected to viral RNA quantification. Four samples obtained from the B.1.1-Akaluc-infected hamsters administrated with AZD7442 were under detection limit of qPCR analysis. (D) Schematic diagram of experimental timeline for the evaluation of the mRNA vaccine mRNA-1273. BALB/c mice (n = 3) were vaccinated (4 μg per dose) twice at the indicated timepoints, and the other BALB/c mice (n = 3) were not vaccinated (were received PBS as a control). Fifty-six weeks after the first vaccination, mice were inoculated with MA10-Akaluc (carrying the S protein of BA.1). Neutralizing antibody titers are shown in
Article Snippet:
Techniques: Bioprocessing, Control, Imaging, Injection, Infection
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: Oocytes injected with ( A ) mCh-Cdc42 (magenta) and wGBD (green), ( B ) mCh-Rho (magenta) and rGBD (green) or C) mCh-Rac (magenta) and wGBD (green) with A’-C’) Corresponding line scans. Scale bar 10 μm, time min:sec. Figure 1—figure supplement 1—source data 1. Amino-terminally tagged RhoGTPases do not localize properly to wounds.
Article Snippet: For expression and purification from E. coli ,
Techniques: Injection
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Left: image of active Cdc42 (magenta) and active Rho (green) around single-cell wound in Xenopus laevis oocyte; right: schematic diagram indicating zone regions; ( B ) Wound in oocyte microinjected with rGBD (active Rho, magenta) and IT-Rho (green); ( B’ ) Line scan of normalized fluorescence intensity from ( B ); ( C ) As in B but with wGBD (active Cdc42, magenta) and IT-Cdc42 (green); ( D,D' ) As in B but with Cy3-Rho (magenta) and rGBD (green); ( E,E' ) As in B but with Cy3-Cdc42 (magenta) and wGBD (green); ( F,F' ) As in B but with Cy3-Rho (magenta) and IT-Rho (green); ( G,G' ) As in B but with Cy3-Cdc42 (magenta) and IT-Cdc42 (green) and line scan. Scale bar 10 μm, time min:sec. Figure 1—source data 1. Direct visualization of Rho and Cdc42 during cell wound repair.
Article Snippet: For expression and purification from E. coli ,
Techniques: Fluorescence
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Cytokinesis in X. laevis embryo microinjected with IT-Rho; IT-Rho accumulates at nascent cleavage furrow (arrowhead); ( B ) Cytokinesis in X. laevis embryo microinjected with Cy3-Rho; Cy3-Rho accumulates at nascent cleavage furrow (arrowhead); ( C ) X. laevis embryo microinjected with IT-Rho (left) and Cy3-Rho (right); both are enriched at cell-cell junctions; ( D ) Meiotically mature Xenopus egg microinjected with IT-Cdc42; IT-Cdc42 is recruited to exocytosing cortical granules (arrowheads) following egg activation (0:42); ( E ) X. laevis embryo microinjected with IT-Cdc42; IT-Cdc42 concentrates at cell-cell junctions (arrowhead; 0:00) and, following damage, is recruited to the wound and becomes enriched at junctions (arrow); ( F ) C3-insensitive IT-Rho rescues Rho activity in presence of C3. Control: oocyte microinjected with rGBD shows normal Rho activation and wound closure; C3: cell microinjected with rGBD fails to activate Rho in presence of C3; IT-Rho-N41V: cell microinjected with rGBD and C3-insensitive IT-Rho activates Rho normally; IT-Rho-N41V+C3: cell microinjected with rGBD and C3-insensitive IT-Rho rescues Rho activity in presence of C3. Scale bar 10 μm, time min:sec; ( G ) Quantification of Rho activity, corrected for background (n = 8–12); ( H ) As in G but with amino-terminally tagged mCh-Rho (n = 8–9). One-way ANOVA with Tukey post-test statistical analysis. *p<0.05, ***p<0.001, ****p<0.0001. Figure 2—source data 1. Directly-labeled Rho and Cdc42 during cytokinesis, cortical granule exocytosis, epithelial wound repair and at junctions.
Article Snippet: For expression and purification from E. coli ,
Techniques: Activation Assay, Activity Assay, Control, Labeling
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Oocytes microinjected with wGBD (green), Cy3-Cdc42 (magenta) and indicated concentrations of mRNA encoding the Cdc42-GAP Abr. Scale bar 10 μm, time min:sec.; ( B ) Quantification of Cy3-Cdc42, active Cdc42 and ratio of active Cdc42 to Cy3-Cdc42 for each condition. n = 8–24. One-way ANOVA with Tukey post-test statistical analysis. *p<0.05, **p<0.01, ***p<0.001, ***p<0.0001. Figure 3—source data 1. Pools of inactive and active Cdc42 at the plasma membrane.
Article Snippet: For expression and purification from E. coli ,
Techniques: Clinical Proteomics, Membrane
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Oocytes microinjected with wGBD (magenta), rGBD (blue) and GDI (green); ( A’ ) Kymograph of wound closure and line scan of radially-averaged fluorescence intensity from ( A ); ( B ) Quantification of distance between peaks (n = 16); ( C ) Wounded oocytes fixed and stained with anti- X. laevis GDI. Scale bar 10 μm, time min:sec. Figure 4—source data 1. RhoGDI is recruited to single-cell wounds enriched in Rho and Cdc42 activity.
Article Snippet: For expression and purification from E. coli ,
Techniques: Fluorescence, Staining, Activity Assay
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Top two rows: oocytes microinjected with Cy3-Cdc42 (magenta) and wGBD (green) alone or with GDI. Bottom two rows: Oocytes microinjected with Cy3-Rho (magenta) and rGBD (green) alone or with GDI; ( B ) Oocytes microinjected with wGBD (magenta), rGBD (green) and increasing concentrations of GDI protein. Scale bar 10 μm, time min:sec; ( C ) Standard curve of Rho and Cdc42 activity with increasing concentrations of GDI (n = 10–23 for each concentration); ( D ) Quantification of Rho and Cdc42 activity at 15.8% above endogenous GDI (n = 17–20). Unpaired student’s t-test, 2-tailed distribution, equal variance statistical analysis. *p<0.05.
Article Snippet: For expression and purification from E. coli ,
Techniques: Activity Assay, Concentration Assay
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Standard curve of Rho and Cdc42 activity with increasing concentrations of bovine GDI (n = 2–30 for each concentration); ( B ) Quantification of Rho and Cdc42 activity at 4.8% above endogenous GDI (n = 24); ( C ) As in B but at 9.6% above endogenous GDI (n = 30–31). Unpaired student’s t-test, 2-tailed distribution, equal variance statistical analysis. *p<0.05, ***p<0.001. Figure 5—figure supplement 2—source data 1. Bovine RhoGDI decreases Rho and Cdc42 activity in a dose-dependent mannerin vivo.
Article Snippet: For expression and purification from E. coli ,
Techniques: Activity Assay, Concentration Assay
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Experimental setup of in vitro experiments: prenylated RhoGTPases were reconstituted on supported lipid bilayers (SLBs) in flow chambers and imaged by TIRF. Wash off experiments were designed to avoid RhoGTPase rebinding to membranes and performed controlling the flow rate via a syringe pump; ( B ) TIRF imaging allows for selective imaging of RhoGTPases at the membrane. Prenylated and unprenylated Cdc42 were imaged in the same conditions and TIRF signal at membranes was quantified (n = 4 for each condition); ( C ) Wash off experiments: prenylated Cdc42 reconstituted on SLBs were washed with imaging buffer only (control), in presence of 5 μM RhoGDI or RabGTTase Beta. Time lapse images at selected time points and quantification of the full experiments are shown. Decay curves were fitted with a monoexponential function; ( D ) Comparison of the K off values obtained by fitting the decay curves (n = 3 for control and RabGTTase Beta, n = 2 for RhoGDI); ( E ) Schematic representation of the proposed mode of action of the two RhoGTPases solubilizers. RabGGTase Beta sequesters RhoGTPases in solution, whereas RhoGDI actively extracts RhoGTPases from the membranes. Scale bar 10 μm. Unpaired student’s t-test, 2-tailed distribution, equal variance statistical analysis. **p<0.01, ***p<0.001, ****p<0.0001. Figure 6—source data 1. RhoGDI extracts RhoGTPases from membranesin vitro.
Article Snippet: For expression and purification from E. coli ,
Techniques: In Vitro, Imaging, Membrane, Control, Comparison
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Wash off experiments: prenylated Cdc42 in both inactive (Cdc42:GDP) and constitutively-active (Cdc42G12V:GTPγS) states were reconstituted on SLBs and washed in presence of 5 μM GDI. Time lapse images at selected time points are shown; ( B ) Quantification of wash off experiments in which the concentration of GDI was titrated between 0 and 20 μM; ( C ) K off values obtained for inactive and constitutively-active Cdc42G12V fitting the decay curves with a monoexponential decay function are plotted against GDI concentration. Extraction rates were fitted with a hyperbolic function; fitting parameters K d and V max are reported in table G; ( D ) Ratio of K off obtained for inactive and constitutively-active Cdc42G12V at the same GDI concentration; ( E–F, H ) Same as in C-D and G for inactive (Rho:GDP) and constitutively-active (RhoG14V:GTPγS) Rho. Scale bar 10 μm. Figure 7—source data 1. RhoGDI extracts both inactive and active RhoGTPases from membranesin vitro.
Article Snippet: For expression and purification from E. coli ,
Techniques: Concentration Assay, Extraction
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Wash off experiments: prenylated Cdc42 in both inactive (Cdc42:GDP) and constitutively-active (Cdc42Q61L:GTP) states were reconstituted on SLBs and washed in presence of 5 μM GDI. Time lapse images at selected time points are shown; ( B ) Quantification of wash off experiments in which the concentration of GDI was titrated between 0 and 20 μM; ( C ) K off values obtained for inactive and constitutively-active Cdc42Q61L fitting the decay curves with a monoexponential decay function are plotted against GDI concentration. Extraction rates were fitted with a hyperbolic function; ( D ) Ratio of K off obtained for inactive and constitutively-active Cdc42Q61L at the same GDI concentration; ( F ) Same as in C-D for inactive (Rho:GDP) and constitutively-active (RhoQ63L:GTP) Rho. Scale bar 10 μm. Figure 7—figure supplement 2—source data 1. RhoGDI extracts both inactive and active RhoGTPases from membranesin vitro.
Article Snippet: For expression and purification from E. coli ,
Techniques: Concentration Assay, Extraction
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: Comparison of K off values obtained for the two constitutively-active variants of Cdc42 (Cdc42G12V and Cdc42Q61L, ( A and C ) and Rho (RhoG14V and RhoQ63L, ( B and D ) from wash off experiments in presence of either WT ( A–B ) or E158/9Q GDI ( C–D ). Extraction rates were fitted with a hyperbolic function.
Article Snippet: For expression and purification from E. coli ,
Techniques: Comparison, Extraction
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) K off values obtained for inactive (Cdc42:GDP) and constitutively-active (Cdc42Q61L:GTP) Cdc42 at different bovine GDI concentrations. Extraction rates were fitted with a hyperbolic function; ( A’ ) Ratio of K off obtained for inactive and constitutively-active Cdc42 at the same bovine GDI concentration; ( B–B’ ) same as in A-A’ for inactive (Rho:GDP) and constitutively-active (RhoQ63L:GTP) Rho. Figure 7—figure supplement 4—source data 1. Comparison of bovine and Xenopus RhoGDI in their ability to extract both inactive and active RhoGTPases from synthetic membranes.
Article Snippet: For expression and purification from E. coli ,
Techniques: Extraction, Concentration Assay, Comparison
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A–I ) Oocytes microinjected with WT or mutant GDI and quantification of localization relative to WT GDI; Unpaired student’s t-test, 2-tailed distribution, unequal variance statistical analysis; ( J ) Average K off values obtained for inactive Rho and Cdc42 in absence (control) and presence of 5 μM of either bovine GDI WT or bovine GDI mutants. Figure 8—figure supplement 1—source data 1. Analysis of previously-described extraction-deficient RhoGDI mutants.
Article Snippet: For expression and purification from E. coli ,
Techniques: Mutagenesis, Control, Extraction
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Oocytes microinjected with halo-tagged WT, Δ51–199, E158/9A and E158/9Q GDI mutants. Scale bar 10 μm, time min:sec; ( B ) Quantification of GDI intensity at wounds (n = 7–13). Unpaired student’s t-test, 2-tailed distribution, unequal variance statistical analysis to WT. ****p<0.0001. ( C ) Comparison of K off values obtained for inactive (Cdc42:GDP, Rho:GDP) and constitutively-active (Cdc42G12V: GTPγS, RhoG14V: GTPγS) Cdc42 and Rho from wash off experiments in presence of either WT (black) or E158/9Q (QQ) (red) GDI. Extraction rates were fitted with a hyperbolic function. Figure 8—source data 1. Identification of mutant RhoGDI deficient in extraction of active RhoGTPase.
Article Snippet: For expression and purification from E. coli ,
Techniques: Comparison, Extraction, Mutagenesis
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A–B ) Comparison of K off values obtained for inactive (Cdc42:GDP, Rho:GDP) and constitutively-active (Cdc42Q61L:GTP, RhoQ63L:GTP) Cdc42 and Rho from wash off experiments in presence of either WT (black) or E158/9Q (QQ) (red) GDI. Extraction rates were fitted with a hyperbolic function. Figure 8—figure supplement 2—source data 1. Mutant E158/9Q RhoGDI is deficient in extraction of constitutively-active Cdc42Q61L and RhoQ63Lin vitro.
Article Snippet: For expression and purification from E. coli ,
Techniques: Comparison, Extraction, Mutagenesis
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: Comparison of K off values obtained for inactive (Cdc42:GDP, Rho:GDP) and constitutively-active (Cdc42Q61L:GTP, RhoQ63L:GTP) Cdc42 and Rho from wash off experiments in presence of either WT (black) or E163/4Q (QQ) (red) bovine GDI. Extraction rates were fitted with a hyperbolic function. Figure 8—figure supplement 3—source data 1. Mutant E163/4Q bovine RhoGDI is deficient in extraction of active Cdc42 and Rhoin vitro.
Article Snippet: For expression and purification from E. coli ,
Techniques: Comparison, Extraction, Mutagenesis
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: Oocytes injected with wGBD alone or with Cdc42 Q61L. Scale bar 10 μm, time min:sec.
Article Snippet: For expression and purification from E. coli ,
Techniques: Injection
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: ( A ) Oocytes microinjected with wGBD alone or with constitutively-active Cdc42 (CA:G12V), WT or QQ GDI; B ) Quantification of total Cdc42 activity for ( A ), (n = 12); C ) oocytes microinjected with Cy3-Cdc42 bound to GTPɣS alone or with WT or QQ GDI; D ) Quantification of intensity for ( C ), (n = 18). Scale bar 10 μm, time min:sec. One-way ANOVA with Tukey post-test statistical analysis; E ) Oocytes microinjected with wGBD (magenta), rGBD (green) alone or with QQ GDI; F ) Quantification of total Cdc42 (magenta) and Rho (green) activity from ( E ) (n = 9); G ) Cy3-Cdc42 or Cy3-Rho alone or with QQ GDI; H ) Quantification of total recruitment of Cy3-Cdc42 (magenta) and Cy3-Rho (green) (n = 6–11). Scale bar 10 μm, time min:sec. Unpaired student’s t-test, 2-tailed distribution, unequal variance statistical analysis. *p<0.05, **p<0.01, ***p<0.001, ***p<0.0001. Figure 9—source data 1. RhoGDI extracts active Cdc42in vivo.
Article Snippet: For expression and purification from E. coli ,
Techniques: Activity Assay
Journal: eLife
Article Title: Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
doi: 10.7554/eLife.50471
Figure Lengend Snippet: Active Rho (green) and active Cdc42 (red) are activated in discrete, concentric zones that close inward as the wound heals. Cdc42 inactivation is variable throughout its zone, thus its zone is shaped by activation . Conversely, the Rho zone is shaped by inactivation as it is subject to RhoGAPs 1/8 at the trailing edge of its zone . Thus, we hypothesize that GDI extracts active Cdc42 throughout the Cdc42 zone and inactive Rho from the trialing edge of the Rho zone.
Article Snippet: For expression and purification from E. coli ,
Techniques: Activation Assay
Journal: Hematology: the American Society of Hematology Education Program
Article Title: Gene therapy for hemophilia
doi: 10.1182/hematology.2019000007
Figure Lengend Snippet: Recent hemophilia B gene therapy trial using AAV
Article Snippet:
Techniques: Plasmid Preparation, Activity Assay, Mutagenesis, Expressing